UC San Diego researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.
Related Articles

News
UC San Diego Data Science Undergrads Help Keep K-12 Students COVID-Safe
December 9, 2021
sandiegobiotech
News, UCSD News
Comments Off on UC San Diego Data Science Undergrads Help Keep K-12 Students COVID-Safe
Since the start of the pandemic, a group of UC San Diego researchers have been meeting weekly with epidemiologists at the County of San Diego Health and Human Services Agency (HHSA) to discuss COVID-19 dynamics,… […]

News
Multi-Tasking Wearable Continuously Monitors Glucose, Alcohol, and Lactate
May 9, 2022
sandiegobiotech
News, UCSD News
Comments Off on Multi-Tasking Wearable Continuously Monitors Glucose, Alcohol, and Lactate
Imagine being able to measure your blood sugar levels, know if you’ve had too much to drink, and track your fatigue during a workout, all in one small device worn on your skin. UC San Diego engineers developed a… […]

News
“Soft” CRISPR May Offer a New Fix for Genetic Defects
July 1, 2022
sandiegobiotech
News, UCSD News
Comments Off on “Soft” CRISPR May Offer a New Fix for Genetic Defects
Scientists have developed a CRISPR-based technology that could offer a safer approach to correcting genetic defects. The new “soft” CRISPR system makes use of natural DNA repair machinery, providing a foundation… […]